Breadcrumb Trail Links News Health Canada ‘One treatment for my disease makes it more likely that I will become a gambler’ Author of the article: Joseph Brean E. Fuller Torrey is a research psychiatrist and expert on schizophrenia who calls Parkinson’s disease, from which he personally suffers, the “weirdest disease” known to medicine. Photo by… Read More »
FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, June 1, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with… Read More »
People with schizophrenia and their healthy siblings share patterns of brain activity that are different from those seen in individuals with no family history of the disorder, scientists from EPFL have found. Because the siblings do not show schizophrenia symptoms, this brain ‘signature’ could serve as a marker for the early diagnosis of the disorder.… Read More »
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology”. 2008 no deaths had been recorded. In 2007, aripiprazole was approved by the FDA for the treatment of unipolar depression when used adjunctively with an antidepressant medication. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology”. Starting… Read More »